This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Alenka Kosak: Innovator in Pharmaceutical Chemistry
Introduction
Alenka Kosak is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. Her work has been recognized for its potential impact on the treatment of gastrointestinal disorders.
Latest Patents
Alenka Kosak holds a patent for a crystalline form of omeprazole. This novel crystalline form, known as omeprazole form C, is characterized by its chemical composition, specifically 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole. The patent also details a process for preparing omeprazole form C, a pharmaceutical formulation containing this form in combination with pharmaceutically acceptable excipients, and its use in treating gastrointestinal disorders. She has 1 patent to her name.
Career Highlights
Alenka Kosak is associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her role at the company has allowed her to focus on innovative drug development and contribute to advancements in pharmaceutical science.
Collaborations
Alenka has collaborated with notable colleagues, including Natasa H Milac and Anton Copar. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.
Conclusion
Alenka Kosak's contributions to pharmaceutical chemistry, particularly through her patent on omeprazole form C, highlight her innovative spirit and dedication to improving healthcare solutions. Her work continues to influence the field and offers promising avenues for future research and development.